Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Mansouri

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Haematologica|January 25, 2020
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center studyAlexander C Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, et al.
Haematologica|December 23, 2017
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapyPanagiotis Baliakas, Mattias Mattsson, Anastasia Hadzidimitriou, et al.
The Lancet. Haematology|April 1, 2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre studyPanagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Blood Cancer Journal|January 4, 2019
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiologyMolly Went, Amit Sud, Helen Speedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesAliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Haematologica|September 29, 2018
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemiaPanagiotis Baliakas, Theodoros Moysiadis, Anastasia Hadzidimitriou, et al.
Haematologica|January 25, 2020
Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multi-center studyAlexander C Leeksma, Panagiotis Baliakas, Theodoros Moysiadis, et al.
Haematologica|December 23, 2017
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapyPanagiotis Baliakas, Mattias Mattsson, Anastasia Hadzidimitriou, et al.
The Lancet. Haematology|April 1, 2016
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre studyPanagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, et al.
Nature Communications|October 20, 2022
Proteogenomics refines the molecular classification of chronic lymphocytic leukemiaSophie A Herbst, Mattias Vesterlund, Alexander J Helmboldt, et al.
Blood|January 31, 2015
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerationsPanagiotis Baliakas, Andreas Agathangelidis, Anastasia Hadzidimitriou, et al.
Leukemia|April 24, 2025
ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarkerBirna Thorvaldsdottir, Larry Mansouri, Lesley-Ann Sutton, et al.
Blood|September 28, 2016
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphomaLarry Mansouri, Daniel Noerenberg, Emma Young, et al.
Blood Cancer Journal|January 4, 2019
Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiologyMolly Went, Amit Sud, Helen Speedy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical OutcomesAliki Xochelli, Panagiotis Baliakas, Ioannis Kavakiotis, et al.
Pageof 7